Sintx Technologies, Inc. (SINT): Nasdaq/NYSE listing notice — SINTX receives Nasdaq bid price deficiency notice; cure deadline April 2024

Sintx Technologies, Inc.

Received Nasdaq notice on Oct 20, 2023 due to bid price below $1.00 for 30 consecutive trading days.
Stock continues trading on Nasdaq Capital Market under symbol SINT; no immediate delisting.
Company has until April 17, 2024 to regain compliance with Listing Rule 5550(a)(2).
If not compliant by then, may be eligible for a 180-day extension, potentially via reverse stock split.
Company will monitor bid price and consider options to cure the deficiency.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Sintx Technologies, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2)

Exact text from the filing

October 20, 2023, SINTX Technologies, Inc. (“SINTX” or “the Company”) received a notice from Nasdaq Listing Qualifications department (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) stating that the bid price of the Company’s common stock for the last 30 consecutive trading days had closed below the minimum $1.00 per share required for continued listing under Listing Rule 5550(a)(2). The Nasdaq notification letter does not result in the immediate delisting of the Company’s common stock, and the stock will continue to trade uninterrupted on the The Nasdaq Capital Market under the symbol

View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Sintx Technologies, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-23-037839

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.